课题基金 / 基金详情

Risk-based protection of participants in un-notified clinical trials No-fault Compensation & Informed Consent-

Risk-based protection of participants in un-notified clinical trials No-fault Compensation & Informed Consent-
对未经通知的临床试验参与者进行基于风险的保护 无过失补偿
批准号:
21590592
负责人:
MURAYAMA Toshinori
金额:
$3.0万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

MURAYAMA Toshinori的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Un-notified clinical trials to the authorities are still allowed in Japan, other than IND/IDE trials. The Ethical Guidelines for Clinical Studies, the only regulation for those, were fundamentally revised and enacted in April 2009, which obligate researchers to take measures on compensation such as insurance in clinical trials to assess pharmaceuticals or medical devices.Since casualty insurance companies have not accumulated know-how to estimate the risk of un-notified trials besides IND/IDE trials, compensation insurance remains inadequate in quality.In order to overcome the situation, we have set a working group of'Risk-based protection of trial participants in un-notified clinical trials' among academic clinical institutes and a casualty company. The working group has investigated legal restriction for insurance, medical expense reduction system in the academic hospital, and an academic guideline for compensation in researcher-initiated un-notified clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2011
期刊: Jpn J Clin Pharmacol Therapeutics
影响因子: --
作者: [Hatta T, Murayama T, Narita K, Sumi E, Yokode M.]
通讯作者: Yokode M.
欧州医薬品審査庁(EMEA)、欧州医薬品委員会(CHMP)ファーマコゲノミクスのサンプル、試験およびデータ処理に関する考察書
欧洲药品管理局 (EMEA)、欧洲医药产品委员会 (CHMP) 药物基因组学样本、测试和数据处理讨论文件
DOI: --
发表时间: 2010
期刊: 臨床評価
影响因子: --
作者: [訳西川昭子, 村山敏典]
通讯作者: 村山敏典
DOI: 10.3892/ijmm.2011.769
发表时间: 2011-11-01
期刊: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
影响因子: 5.4
作者: [Tamura, Yukinori, Murayama, Toshinori, Arai, Hidenori]
通讯作者: Arai, Hidenori
欧州医薬品審査庁(EMEA)、欧州医薬品委員会(CHMP)ヒト細胞由来医薬品に関するガイドライン
欧洲药品管理局 (EMEA)、欧洲药品委员会 (CHMP) 人体细胞衍生药品指南
DOI: --
发表时间: 2010
期刊: 臨床評価
影响因子: --
作者: [訳西川昭子, 村山敏典]
通讯作者: 村山敏典
37
    The Consolidation of Ethical Infrastructures Supporting Clinical Trials for the Development of Advanced Medicine Technology
    • 批准号:
      19602002
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2007
    • 负责人:
      MURAYAMA Toshinori
    • 依托单位: